MsMartina Murphy

A Phase 2, Open-Label, Randomized, Master Protocol Dose Optimization Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Mirvetuximab Soravtansine in Subjects With Ovarian Cancer

A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Implementation of a Cancer Clinical Trials (CCT) Communication Skills Education Program for Medical Oncology Fellows

Incentive funds for Graduate Medical Education Trainees

Clinical Trials Education in GME: A Needs Assessment

S.E.N.D.: Developing a web-based, interactive guide to enhance patient-clinician electronic communication by focusing on specificity, expressing concerns, need, and directness

A Phase II Study of Abemaciclib in Combination with Letrozole in Advanced, Recurrent or Metastatic Endometrioid Endometrial Cancer

APIXABAN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER: A PROSPECTIVE RANDOMIZED OPEN BLINDED END-POINT (PROBE) STUDY - THE CARAVAGGIO STUDY